Jacobs Levy Equity Management Inc. Has $4.63 Million Stock Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Jacobs Levy Equity Management Inc. increased its holdings in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 16.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 128,976 shares of the company's stock after acquiring an additional 18,490 shares during the period. Jacobs Levy Equity Management Inc. owned about 0.68% of USANA Health Sciences worth $4,629,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of USNA. R Squared Ltd acquired a new stake in USANA Health Sciences during the fourth quarter valued at $28,000. KLP Kapitalforvaltning AS acquired a new stake in USANA Health Sciences during the fourth quarter valued at $83,000. Quantbot Technologies LP acquired a new stake in USANA Health Sciences during the fourth quarter valued at $132,000. Meeder Asset Management Inc. acquired a new stake in USANA Health Sciences during the fourth quarter valued at $143,000. Finally, Amundi boosted its position in USANA Health Sciences by 85.3% during the fourth quarter. Amundi now owns 4,872 shares of the company's stock valued at $170,000 after purchasing an additional 2,243 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.

Insider Activity

In related news, CFO G Doug Iiekking sold 4,548 shares of the business's stock in a transaction dated Friday, May 9th. The stock was sold at an average price of $29.61, for a total transaction of $134,666.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider David Mulham Mulham sold 3,234 shares of the business's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $32.98, for a total value of $106,657.32. Following the transaction, the insider now directly owns 12,775 shares of the company's stock, valued at $421,319.50. This represents a 20.20% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,142 shares of company stock valued at $655,050. 0.63% of the stock is owned by insiders.

USANA Health Sciences Stock Up 0.9%

Shares of NYSE:USNA traded up $0.27 on Tuesday, reaching $30.34. The company had a trading volume of 16,097 shares, compared to its average volume of 130,877. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $49.78. The stock has a 50-day moving average price of $27.03 and a 200 day moving average price of $32.35. The stock has a market capitalization of $564.93 million, a P/E ratio of 10.72, a P/E/G ratio of 0.93 and a beta of 0.60.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share for the quarter, topping analysts' consensus estimates of $0.70 by $0.03. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $249.54 million during the quarter, compared to analysts' expectations of $243.08 million. During the same quarter in the previous year, the firm earned $0.86 earnings per share. On average, sell-side analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

USNA has been the subject of a number of research reports. StockNews.com cut USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Sidoti cut USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 18th. Finally, DA Davidson reduced their price target on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research report on Thursday, February 27th.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.